Bioplastic Packaging
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Biopharmaceutical Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Other
1.3 Market by Application
1.3.1 Global Biopharmaceutical Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Market Perspective (2017-2028)
2.2 Biopharmaceutical Growth Trends by Region
2.2.1 Biopharmaceutical Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biopharmaceutical Historic Market Size by Region (2017-2022)
2.2.3 Biopharmaceutical Forecasted Market Size by Region (2023-2028)
2.3 Biopharmaceutical Market Dynamics
2.3.1 Biopharmaceutical Industry Trends
2.3.2 Biopharmaceutical Market Drivers
2.3.3 Biopharmaceutical Market Challenges
2.3.4 Biopharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Players by Revenue
3.1.1 Global Top Biopharmaceutical Players by Revenue (2017-2022)
3.1.2 Global Biopharmaceutical Revenue Market Share by Players (2017-2022)
3.2 Global Biopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical Revenue
3.4 Global Biopharmaceutical Market Concentration Ratio
3.4.1 Global Biopharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Revenue in 2021
3.5 Biopharmaceutical Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical Product Solution and Service
3.7 Date of Enter into Biopharmaceutical Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Breakdown Data by Type
4.1 Global Biopharmaceutical Historic Market Size by Type (2017-2022)
4.2 Global Biopharmaceutical Forecasted Market Size by Type (2023-2028)
5 Biopharmaceutical Breakdown Data by Application
5.1 Global Biopharmaceutical Historic Market Size by Application (2017-2022)
5.2 Global Biopharmaceutical Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biopharmaceutical Market Size (2017-2028)
6.2 North America Biopharmaceutical Market Size by Country (2017-2022)
6.3 North America Biopharmaceutical Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Biopharmaceutical Market Size (2017-2028)
7.2 Europe Biopharmaceutical Market Size by Country (2017-2022)
7.3 Europe Biopharmaceutical Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Market Size (2017-2028)
8.2 Asia-Pacific Biopharmaceutical Market Size by Country (2017-2022)
8.3 Asia-Pacific Biopharmaceutical Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Biopharmaceutical Market Size (2017-2028)
9.2 Latin America Biopharmaceutical Market Size by Country (2017-2022)
9.3 Latin America Biopharmaceutical Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Market Size (2017-2028)
10.2 Middle East & Africa Biopharmaceutical Market Size by Country (2017-2022)
10.3 Middle East & Africa Biopharmaceutical Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Biopharmaceutical Introduction
11.1.4 Roche Revenue in Biopharmaceutical Business (2017-2022)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Biopharmaceutical Introduction
11.2.4 Amgen Revenue in Biopharmaceutical Business (2017-2022)
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Biopharmaceutical Introduction
11.3.4 AbbVie Revenue in Biopharmaceutical Business (2017-2022)
11.3.5 AbbVie Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Detail
11.4.2 Sanofi-Aventis Business Overview
11.4.3 Sanofi-Aventis Biopharmaceutical Introduction
11.4.4 Sanofi-Aventis Revenue in Biopharmaceutical Business (2017-2022)
11.4.5 Sanofi-Aventis Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Biopharmaceutical Introduction
11.5.4 Johnson & Johnson Revenue in Biopharmaceutical Business (2017-2022)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Biopharmaceutical Introduction
11.6.4 Pfizer Revenue in Biopharmaceutical Business (2017-2022)
11.6.5 Pfizer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Detail
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Biopharmaceutical Introduction
11.7.4 Novo Nordisk Revenue in Biopharmaceutical Business (2017-2022)
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Detail
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Biopharmaceutical Introduction
11.8.4 Eli Lilly Revenue in Biopharmaceutical Business (2017-2022)
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Biopharmaceutical Introduction
11.9.4 Novartis Revenue in Biopharmaceutical Business (2017-2022)
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Biopharmaceutical Introduction
11.10.4 Merck Revenue in Biopharmaceutical Business (2017-2022)
11.10.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biopharmaceutical Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Erythropoietin
Table 5. Key Players of Insulin
Table 6. Key Players of Other
Table 7. Global Biopharmaceutical Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Biopharmaceutical Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Biopharmaceutical Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Biopharmaceutical Market Share by Region (2017-2022)
Table 11. Global Biopharmaceutical Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Biopharmaceutical Market Share by Region (2023-2028)
Table 13. Biopharmaceutical Market Trends
Table 14. Biopharmaceutical Market Drivers
Table 15. Biopharmaceutical Market Challenges
Table 16. Biopharmaceutical Market Restraints
Table 17. Global Biopharmaceutical Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Biopharmaceutical Market Share by Players (2017-2022)
Table 19. Global Top Biopharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical as of 2021)
Table 20. Ranking of Global Top Biopharmaceutical Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Biopharmaceutical Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Biopharmaceutical Product Solution and Service
Table 24. Date of Enter into Biopharmaceutical Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biopharmaceutical Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Biopharmaceutical Revenue Market Share by Type (2017-2022)
Table 28. Global Biopharmaceutical Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Biopharmaceutical Revenue Market Share by Type (2023-2028)
Table 30. Global Biopharmaceutical Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Biopharmaceutical Revenue Market Share by Application (2017-2022)
Table 32. Global Biopharmaceutical Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Biopharmaceutical Revenue Market Share by Application (2023-2028)
Table 34. North America Biopharmaceutical Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Biopharmaceutical Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Biopharmaceutical Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Biopharmaceutical Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Biopharmaceutical Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Biopharmaceutical Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Biopharmaceutical Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Biopharmaceutical Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Biopharmaceutical Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Biopharmaceutical Market Size by Country (2023-2028) & (US$ Million)
Table 44. Roche Company Detail
Table 45. Roche Business Overview
Table 46. Roche Biopharmaceutical Product
Table 47. Roche Revenue in Biopharmaceutical Business (2017-2022) & (US$ Million)
Table 48. Roche Recent Development
Table 49. Amgen Company Detail
Table 50. Amgen Business Overview
Table 51. Amgen Biopharmaceutical Product
Table 52. Amgen Revenue in Biopharmaceutical Business (2017-2022) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. AbbVie Company Detail
Table 55. AbbVie Business Overview
Table 56. AbbVie Biopharmaceutical Product
Table 57. AbbVie Revenue in Biopharmaceutical Business (2017-2022) & (US$ Million)
Table 58. AbbVie Recent Development
Table 59. Sanofi-Aventis Company Detail
Table 60. Sanofi-Aventis Business Overview
Table 61. Sanofi-Aventis Biopharmaceutical Product
Table 62. Sanofi-Aventis Revenue in Biopharmaceutical Business (2017-2022) & (US$ Million)
Table 63. Sanofi-Aventis Recent Development
Table 64. Johnson & Johnson Company Detail
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Biopharmaceutical Product
Table 67. Johnson & Johnson Revenue in Biopharmaceutical Business (2017-2022) & (US$ Million)
Table 68. Johnson & Johnson Recent Development
Table 69. Pfizer Company Detail
Table 70. Pfizer Business Overview
Table 71. Pfizer Biopharmaceutical Product
Table 72. Pfizer Revenue in Biopharmaceutical Business (2017-2022) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Novo Nordisk Company Detail
Table 75. Novo Nordisk Business Overview
Table 76. Novo Nordisk Biopharmaceutical Product
Table 77. Novo Nordisk Revenue in Biopharmaceutical Business (2017-2022) & (US$ Million)
Table 78. Novo Nordisk Recent Development
Table 79. Eli Lilly Company Detail
Table 80. Eli Lilly Business Overview
Table 81. Eli Lilly Biopharmaceutical Product
Table 82. Eli Lilly Revenue in Biopharmaceutical Business (2017-2022) & (US$ Million)
Table 83. Eli Lilly Recent Development
Table 84. Novartis Company Detail
Table 85. Novartis Business Overview
Table 86. Novartis Biopharmaceutical Product
Table 87. Novartis Revenue in Biopharmaceutical Business (2017-2022) & (US$ Million)
Table 88. Novartis Recent Development
Table 89. Merck Company Detail
Table 90. Merck Business Overview
Table 91. Merck Biopharmaceutical Product
Table 92. Merck Revenue in Biopharmaceutical Business (2017-2022) & (US$ Million)
Table 93. Merck Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical Market Share by Type: 2021 VS 2028
Figure 2. Monoclonal Antibodies Features
Figure 3. Interferon Features
Figure 4. Erythropoietin Features
Figure 5. Insulin Features
Figure 6. Other Features
Figure 7. Global Biopharmaceutical Market Share by Application in 2021 & 2028
Figure 8. Tumor Case Studies
Figure 9. Diabetes Case Studies
Figure 10. Cardiovascular Case Studies
Figure 11. Hemophilia Case Studies
Figure 12. Other Case Studies
Figure 13. Biopharmaceutical Report Years Considered
Figure 14. Global Biopharmaceutical Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Biopharmaceutical Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Biopharmaceutical Market Share by Region: 2021 VS 2028
Figure 17. Global Biopharmaceutical Market Share by Players in 2021
Figure 18. Global Top Biopharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Biopharmaceutical Revenue in 2021
Figure 20. North America Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Biopharmaceutical Market Share by Country (2017-2028)
Figure 22. United States Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Biopharmaceutical Market Share by Country (2017-2028)
Figure 26. Germany Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Biopharmaceutical Market Share by Region (2017-2028)
Figure 34. China Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Biopharmaceutical Market Share by Country (2017-2028)
Figure 42. Mexico Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Biopharmaceutical Market Share by Country (2017-2028)
Figure 46. Turkey Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Biopharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Biopharmaceutical Business (2017-2022)
Figure 49. Amgen Revenue Growth Rate in Biopharmaceutical Business (2017-2022)
Figure 50. AbbVie Revenue Growth Rate in Biopharmaceutical Business (2017-2022)
Figure 51. Sanofi-Aventis Revenue Growth Rate in Biopharmaceutical Business (2017-2022)
Figure 52. Johnson & Johnson Revenue Growth Rate in Biopharmaceutical Business (2017-2022)
Figure 53. Pfizer Revenue Growth Rate in Biopharmaceutical Business (2017-2022)
Figure 54. Novo Nordisk Revenue Growth Rate in Biopharmaceutical Business (2017-2022)
Figure 55. Eli Lilly Revenue Growth Rate in Biopharmaceutical Business (2017-2022)
Figure 56. Novartis Revenue Growth Rate in Biopharmaceutical Business (2017-2022)
Figure 57. Merck Revenue Growth Rate in Biopharmaceutical Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche Amgen AbbVie Sanofi-Aventis Johnson & Johnson Pfizer Novo Nordisk Eli Lilly Novartis Merck